NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Of course we’ve heard that LP is not motivated by money, so she might be fine with walking away with a nice tidy gain even at a lower share price.

My point about the 20+ billion acquisition is not so much related to L, since that will convert into cash flow almost immediately and offset some of the dilution and uncertainty. The bigger problem is how to value D, which is years away from completing trials all the way through approvals, and what a buyer would be willing to pay for that platform. $20 billion is in the realm of possibility. Buy going beyond that for the entire company is highly unlikely, IMHO.

Since this is a MB, I’ll brainstorm an idea: Sell NWBO with just the rights to L and associated patents, and spin off the other assets for D into a separate entity. Shareholders in NWBO would receive the proceeds//shares from the sale of the public company, plus newly issued shares in the newco that holds the rights ands patents for D. The concept would actually work, but it gets messy since some patents are shared and the newco would need to be adequately capitalized,